Publications by authors named "Jane Shull"

Claim this Profile
C
Community engagement group model in basic and biomedical research: lessons learned from the BEAT-HIV Delaney Collaboratory towards an HIV-1 cure.
Karine Dubé, Beth Peterson, Nora L Jones, Amy Onorato, William B Carter, Jane Shull

Res Involv Engagem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients.
Emmanouil Papasavvas, Andrea Foulkes, Xiangfan Yin, Jocelin Joseph, Brian Ross, Jane Shull

Immunology· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased metallothionein gene expression, zinc, and zinc-dependent resistance to apoptosis in circulating monocytes during HIV viremia.
Andrea D Raymond, Bethsebah Gekonge, Malavika S Giri, Aidan Hancock, Emmanouil Papasavvas, Jane Shull

J Leukoc Biol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance.
Malavika S Giri, Michael Nebozyhn, Andrea Raymond, Bethsebah Gekonge, Aidan Hancock, Jane Shull

J Immunol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjects.
Emmanouil Papasavvas, Elizabeth C Moore, Junwei Sun, Livio Azzoni, Maxwell Pistilli, Jane Shull

AIDS Res Hum Retroviruses· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy.
Emmanouil Papasavvas, Livio Azzoni, Maxwell Pistilli, Aidan Hancock, Griffin Reynolds, Jane Shull

AIDS· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.
Emmanouil Papasavvas, Jay R Kostman, Karam Mounzer, Robert M Grant, Robert Gross, Jane Shull

PLoS Med· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients.
Emmanouil Papasavvas, Robert M Grant, Junwei Sun, Agnieska Mackiewicz, Maxwell Pistilli, Jane Shull

AIDS· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplementing antiretroviral therapy.
George M Carter, Richard Elion, Mark Kuebel, Janet Mindes, Devan Nambiar, Jane Shull

Science· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis